Effect of theophylline on endogenous hydrogen sulfide in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006
Elevated concentration of exhaled hydrogen peroxide in patients with asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 166s Year: 2001
The effect of inhaled corticosteroids on hydrogen peroxide exhalation in stable COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 337s Year: 2001
Endogenous hydrogen sulfide (H2 S) in serum and sputum as novel biomarker of asthma Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
The interrelationship of the inflammatory markers in blood and sputum of stable COPD patients before and after treatment with inhaled steroids and N-acetylcysteine Source: Eur Respir J 2003; 22: Suppl. 45, 281s Year: 2003
Increased concentration of hydrogen peroxide (H2 O2 ) in expired breath condensate of patients with lung cancer and stable chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001
Sputum neutrophil monitoring is useful for long-term oxygen therapy in patients with COPD Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012
Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002
Clinical application of sputum hydrogen sulfide and YKL-40 in Asthma, ACO and COPD Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Effect of ICS withdrawal on COPD exacerbations in patients on triple therapy at baseline Source: International Congress 2018 – COPD management Year: 2018
Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 309s Year: 2002
Enhanced level of hydrogen peroxide in expired breath correlates with the plasma concentration of TNFa in patients with lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004
Can treatment with tiotropium influence nitrate stress in the COPD patients? Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006
The dynamic of pH, hydrogen peroxide and nitrite in exhaled breath condensate from patients with COPD and asthma exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Hydrogen sulfide (H2 S) in sputum and serum as a novel biomarker of COPD Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014
A new method for measuring hydrogen peroxide concentration in exhaled air in stable COPD patients: reproducibilityand stability Source: Eur Respir J 2001; 18: Suppl. 33, 460s Year: 2001
Monitoring the effect of fixed combination therapy by exhaled biomarkers in asthmatic children Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007
The influence of complex ICS/LABA therapy on oxygen consumption in COPD patients Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities Year: 2014
The effect of oral corticosteroid on spirometeric parameters in COPD patients induced by mustard gas Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006